We are live on
!
Find out more
Inovio Pharmaceuticals
25 hedge funds and large institutions have $5.36M invested in Inovio Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
0.08% more ownership
Funds ownership: 0% → 0.08% (+0.08%)
Holders
25
Holders Change
+25
Holders Change %
–
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
INO Hedge Fund Activity: Q2 2013 in Review
25 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q2 2013, worth a combined $5.36M.
Buyers outnumbered sellers: 25 funds opened new INO positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.
- 25 institutional investors held Inovio Pharmaceuticals (INO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $5.36M of Inovio Pharmaceuticals stock for Q2 2013.
- 25 funds opened new Inovio Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +25 holders.
Based on aggregated 13F filings for Q2 2013.